We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Directorate Changes

30 Jul 2018 07:00

RNS Number : 0813W
Nanoco Group PLC
30 July 2018
 

30 July 2018

NANOCO GROUP PLC

("Nanoco" or the "Company")

 

Directorate Changes

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, today announces that, as part of a structured reorganisation of the Company's executive team following Keith Wiggins resignation as Chief Operating Officer in June, Nanoco will combine its Chief Financial Officer and Chief Operating Officer positions into one unified role.

 

The Board is pleased to announce that Brian Tenner has been appointed to this new combined role, effective from 20 August 2018. Brian is currently Chief Financial Officer of NCC Group plc ("NCC"), a leading pure play cyber security advisory business. On the 20 June 2018 it was announced that Brian would leave NCC in August 2018. Previously he was Group Finance Director and a member of the Board at Renold Plc (2010-2016), Scapa Group Plc (2007-2010) and BNFL Plc - British Nuclear Group (2003-2007).

 

As a result of the reorganisation, David Blain will stand down from his position as Chief Financial Officer on the 20 August 2018. David will remain with Nanoco until 15 October 2018 to facilitate an orderly handover of his duties.

 

There is no further information to be disclosed relating to Brian under paragraph 9.6.13 of the UK Listing Authority Listing Rules.

 

Michael Edelman, Chief Executive of Nanoco, said:

 

"On behalf of the whole team, I would like to thank David for the very significant contribution he has made to Nanoco as our Chief Financial Officer over the past three years. He has been a key part of the team as we have driven our commercialisation strategy and maintained robust financing and tight control over costs. We wish him well for all his future endeavours.

 

"I would like to welcome Brian to the team in this newly created role. His extensive experience will be invaluable to our Executive Team and the Board as Nanoco continues to gain commercial momentum."

 

- Ends -

 

 

For further information, please contact:

Nanoco

Tel: +44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer

 

Chris Richards, Non-Executive Chairman

 

Caroline Watson, Investor Relations Manager

Tel: + 44 (0) 7799 897357

cwatson@nanocotechnologies.com

 

 

 

 

MHP Communications

Tel: +44 (0) 20 3128 8570

Reg Hoare / Giles Robinson / Pete Lambie

nanoco@mhpc.com

 

 

The information contained within this announcement constitutes inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014.

 

Notes for editors:

 

About Nanoco Group plc

Nanoco (LSE: NANO) harnesses the power of nano-technology to create a brighter, more sustainable future. Based on breakthrough science, Nanoco's proprietary manufacturing process enables the large-scale production of its cadmium-free CFQD® quantum dots for multiple applications including LCD display, lighting, healthcare, nano-materials and solar.

Nanoco has non-exclusive manufacturing and marketing licensing agreements in display with The Dow Chemical Company, Merck KGaA of Germany and Wah Hong Industrial Corporation of Taiwan.

Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.

Nanoco is listed on the Main Market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com. 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAZVLFLVDFBBBE

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.